Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

Welcome and Introduction to Vi3C

Opportunities to Optimize Cancer Policies Panel Discussion

Advertisement

Advertisement




Oct
21
Today In Oncology
Bivalent CAR T-Cell Therapy Shows No Delayed Toxicity and Promising Survival in Recurrent Glioblastoma
Claudia Henschke, PhD, MD Finding Lung Cancer in Time
Starting Surveillance Colonoscopy After High-Risk Adenoma Removal When Is the Right Time
Evolving Strategies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
AI Model Based on Facial Image Analysis Estimates Biological Age and Mortality Risk in Patients With Cancer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo